scholarly journals The successful accomplishment of nutritional and clinical outcomes via the implementation of a multidisciplinary nutrition support team in the neonatal intensive care unit

2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Eurim Jeong ◽  
Young Hwa Jung ◽  
Seung Han Shin ◽  
Moon Jin Kim ◽  
Hye Jung Bae ◽  
...  
2021 ◽  
Vol 15 ◽  
Author(s):  
Esther M. Hazelhoff ◽  
Jeroen Dudink ◽  
Johanna H. Meijer ◽  
Laura Kervezee

The circadian timing system optimizes health by temporally coordinating behavior and physiology. During mammalian gestation, fetal circadian rhythms are synchronized by the daily fluctuations in maternal body temperature, hormones and nutrients. Circadian disruption during pregnancy is associated with negative effects on developmental outcomes in the offspring, highlighting the importance of regular and robust 24-h rhythms over gestation. In the case of preterm birth (before 37 weeks of gestation), maternal cues no longer synchronize the neonate’s circadian system, which may adversely affect the neonate. There is increasing evidence that introducing robust light-dark cycles in the Neonatal Intensive Care Unit has beneficial effects on clinical outcomes in preterm infants, such as weight gain and hospitalization time, compared to infants exposed to constant light or constant near-darkness. However, the biological basis for these effects and the relationship with the functional and anatomical development of the circadian system is not fully understood. In this review, we provide a concise overview of the effects of light-dark cycles on clinical outcomes of preterm neonates in the NICU and its alignment with the development of the circadian system.


Neonatology ◽  
2006 ◽  
Vol 91 (4) ◽  
pp. 241-247 ◽  
Author(s):  
Young Hee Kim ◽  
Sung Soo Chang ◽  
Yang Soo Kim ◽  
Ellen Ai-Rhan Kim ◽  
Sung Cheol Yun ◽  
...  

2018 ◽  
Vol 23 (3) ◽  
pp. 209-214 ◽  
Author(s):  
Chad A. Knoderer ◽  
David M. Kaylor ◽  
Meghan E. Toth ◽  
Katherine M. Malloy ◽  
Kristen R. Nichols

OBJECTIVES The objective of this study was to characterize clinical outcomes when cefepime was used in a neonatal intensive care population. METHODS Data were extracted from the medical records of all full-term (40 weeks gestational age) patients up to 2 months of age and preterm patients up to 48 weeks postmenstrual age admitted to the neonatal intensive care unit (NICU) at a freestanding children's hospital between January 1, 2010, and December 31, 2013, who received at least 48 hours of cefepime. The primary outcome measure was a positive clinical response as defined by a normalization of white blood cell count and/or culture clearance. RESULTS Final analysis included 74 patients. Clinical response was evaluable in 43.2% (32 of 74) of courses. Of these, positive clinical response was observed in 81.3% (26 of 32). Overall patient mortality was 16.2% (12 of 74). Adverse effects (AEs) occurred in 14.9% (11 of 74) of courses. CONCLUSIONS Cefepime can be used safely with reasonable clinical response in a NICU population, but additional studies are needed to further determine cefepime-associated clinical outcomes.


Sign in / Sign up

Export Citation Format

Share Document